Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT03441334 Terminated - Stroke Clinical Trials

rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke

Start date: November 12, 2018
Phase: N/A
Study type: Interventional

The study will enroll 5 individuals post-stroke to examine the feasibility and efficacy of a high frequency repetitive transcranial magnetic stimulation (rTMS) combined with body weight supported treadmill training.

NCT ID: NCT03436277 Not yet recruiting - Body Weight Changes Clinical Trials

Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training

Start date: December 17, 2018
Phase: Phase 2
Study type: Interventional

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.

NCT ID: NCT03422380 Completed - Obesity Clinical Trials

Energy Expenditure and Weight Loss Maintenance

Start date: October 2009
Phase: N/A
Study type: Observational

Obesity is reaching epidemic proportions and threatens both health and quality of life of people around the world. While many individuals succeed at short term weight loss, weight loss maintenance is the greatest barrier to successful treatment of obesity. High levels of physical activity are consistently associated with success in weight loss maintenance. The major goal of this proposal is to understand how and why high levels of physical activity are critical for long term maintenance of weight loss. This project takes advantage of the National Weight Control Registry (NWCR), which follows over 6000 individuals who have maintained a weight loss of ≥30 pounds for ≥1 year. Understanding how individuals successful at weight loss maintenance achieve energy balance will provide important insight into strategies to help more people sustain a weight loss.

NCT ID: NCT03415997 Completed - Clinical trials for Contrast Media Dosing

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight

Start date: February 21, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups based on contrast dosing technique, and solid organ enhancement at uniphasic abdominal CT will be measured.

NCT ID: NCT03411902 Completed - Weight Loss Clinical Trials

Weight Loss With Risedronate for Bone Health

WERISE
Start date: June 15, 2018
Phase: Phase 4
Study type: Interventional

This is a pilot project to determine the feasibility of recruiting, enrolling, treating, and following 24 older sleeve gastrectomy patients into a randomized controlled trial (RCT) examining the efficacy of bisphosphonate use versus placebo in the prevention of surgical weight loss associated loss of bone mass and quality.

NCT ID: NCT03405181 Completed - Infant Development Clinical Trials

Effects of the Additional Weight on the Reaching Behavior of Pre Term Infants With Low Birth Weight

Start date: January 12, 2018
Phase: N/A
Study type: Interventional

The effects of additional weight on early motor skills of infants have been increasingly studied. During the reaching behavior, the additional weight has been shown benefits in certain kinematic variables in full term and preterm infants. There is a growing interest in the study of populations at risk for motor development, especially considering interventions based on functional activities with the purpose of improving the neuromotor control, functional capacity and muscle strength. The aim of the present study is to investigate the effect of a functional training with additional weight in the reaching behavior of preterm infants with low birth weight and to compare the effects with a full term population. A controlled and randomized trial will be carried out with full term infants of adequate birth weight and preterm infants with low birth weight at 6 months of chronological or corrected age. The participants will be recruited by convenience from the charts of a Public Hospital. Participants will be randomly allocated into four groups: 1) adequate weight placebo group (AWPG); 2) adequate weight intervention group (AWIG); 2) low weight placebo group (LWPG) and 4) low weight intervention group (LWIG). . The assessor will be blinded (no knowledge of groups allocation). All infants will undergo a training program of eight sessions (2x/week; 4 weeks). The AWIG and LWIG will receive the training with an additional weight (characterized by a bracelet with a weight of 20% of the mass of the upper limbs)and the AWPG and LWPG will receive the same training, however, without the additional weight (only the bracelets).. All infants will be assessed in three different moments: 1) Pre-intervention: baseline, before the start of the intervention program; 2) Post-intervention: evaluation performed after the end of the program; and 3) Follow-up: evaluation performed seven days after the post-intervention assessment. The following kinematic dependent variables will be calculated: straightness index, mean velocity and motion units and electromyographic variables: pattern of activation and recruitment of muscle fibers - Biceps brachialis, Triceps brachialis, Deltoid and Pectoralis Major muscles; co-activation between biceps and triceps. The Qualisys Track Manager (QTM) and a wireless surface electromyography with 8-channels will be used. If normality assumptions are met, a mixed 2X2 ANOVA with repeated measures will be applied, in order to verify differences between the intervention programs, considering the dependent variables. Otherwise, non-parametric procedures of the same nature will be adopted. The significance will be set at 5% (P<0.05).

NCT ID: NCT03403530 Completed - Neonatal SEPSIS Clinical Trials

Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

IgMNS
Start date: January 30, 2018
Phase: Phase 4
Study type: Interventional

Study comprises of giving IVIG to half of the septic VLBW preterm neonates along with ongoing antibiotics and placebo to the other half. The immunoglobulin will be given for 3 days and neonates will be monitored for the results. The data will be analysed on the basis of blood culture results and outcome of the patients.

NCT ID: NCT03397940 Completed - Physical Activity Clinical Trials

Role of Structured Days on Weight Gain

Start date: March 1, 2018
Phase:
Study type: Observational

Summer vacation is a 3-month window of vulnerability for children from low-income households when health behaviors and academic learning decay. The goal of this project is to collect information on where low-income children go during summer, what they do when they get there, and how their behaviors (physical activity, sedentary, sleep, and diet) differ between the summer (unstructured days) and school year (structured days). This study is 1) significant because it will provide evidence on potential points of intervention that can reduce or reverse the excessive unhealthy weight gains that occur during summer and 2) innovative because it will be the first to identify changes in activity, sedentary, sleep, and dietary behaviors during prolonged and shorter periodic breaks from school and link these behaviors to changes in zBMI over time.

NCT ID: NCT03396029 Completed - Physical Activity Clinical Trials

Tailored Written Lifestyle Feedback in Colorectal Cancer Screening

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to investigate the effect of an individually tailored lifestyle feedback letter and a leaflet on lifestyle in the context of sigmoidoscopy screening.

NCT ID: NCT03395262 Completed - Weight Loss Clinical Trials

An Examination of a Weight Loss Formula on Health

NB14
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.